General Information of Drug Transporter (DT)
DT ID DTD0130 Transporter Info
Gene Name SLC1A2
Transporter Name Excitatory amino acid transporter 2
Gene ID
6506
UniProt ID
P43004

Transcriptional Regulation of This DT (TSR)

TF Superclass1: Basic domains

      Class1.2: Basic helix-loop-helix factors

Click to Show/Hide the Full List of 7 TF(s) Regulating This DT

        AHR 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC1A2 gene in breast cancer condition [1]

TF Protein Name

Aryl hydrocarbon receptor Transcription Factor Info

Affected Drug/Substrate

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Aryl hydrocarbon receptor (AHR) has been reported to activate the transcription of SLC1A2 gene in breast cancer condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 2.

        ARNT 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC1A2 gene in breast cancer condition [1]

TF Protein Name

Aryl hydrocarbon receptor nuclear translocator Transcription Factor Info

Affected Drug/Substrate

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Aryl hydrocarbon receptor nuclear translocator (ARNT) has been reported to activate the transcription of SLC1A2 gene in breast cancer condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 2.

        ASCL1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC1A2 gene [2]

TF Protein Name

Achaete-scute homolog 1 Transcription Factor Info

Tissue

Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Achaete-scute homolog 1 (ASCL1) can directly bind to the SLC1A2 gene, which in turn affects the expression or function of the drug transporter Excitatory amino acid transporter 2.

        MITF 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC1A2 gene in melanoma condition [3]

TF Protein Name

Microphthalmia-associated transcription factor Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Microphthalmia-associated transcription factor (MITF) has been reported to activate the transcription of SLC1A2 gene in melanoma condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 2.

        MYC 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC1A2 gene in embryonic stem cells condition [4]

TF Protein Name

Myc proto-oncogene protein Transcription Factor Info

Related DT Changes

Direct regulating

Detailed Description

Myc proto-oncogene protein (MYC) has been reported to bind to the transcription of SLC1A2 gene in embryonic stem cells condition, which leads to an affected expression of the drug transporter Excitatory amino acid transporter 2.

        MYCN 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Repression of SLC1A2 gene in astrocytoma condition [5]

TF Protein Name

N-myc proto-oncogene protein Transcription Factor Info

Studied Phenotype

Astrocytoma [ICD11: 2A00.0Y]

Tissue

Brain

Related DT Changes

Down regulating

Experimental Material

Human astrocytoma cells (HTB-148)

Detailed Description

N-myc proto-oncogene protein (MYCN) has been reported to repress the transcription of SLC1A2 gene in astrocytoma condition, which leads to a decreased expression of the drug transporter Excitatory amino acid transporter 2.

        TCF4 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC1A2 gene in glioblastoma multiforme condition [6]

TF Protein Name

Transcription factor 4 Transcription Factor Info

Affected Drug/Substrate

Temozolomide

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Transcription factor 4 (TCF4) has been reported to activate the transcription of SLC1A2 gene in glioblastoma multiforme condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 2.

      Class1.3: Basic helix-span-helix factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        TFAP2A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC1A2 gene in MCF7 cells [7]

TF Protein Name

Transcription factor AP-2-alpha Transcription Factor Info

Related DT Changes

Direct regulating

Detailed Description

Transcription factor AP-2-alpha (TFAP2A) has been reported to bind to the transcription of SLC1A2 gene in MCF7 cells, which leads to an affected expression of the drug transporter Excitatory amino acid transporter 2.

TF Superclass2: Zinc-coordinating DNA-binding domains

      Class2.1: Nuclear receptors with C4 zinc fingers

Click to Show/Hide the Full List of 3 TF(s) Regulating This DT

        AR 

Click to Show/Hide to Show 2 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC1A2 gene [8]

TF Protein Name

Androgen receptor Transcription Factor Info

Related DT Changes

Direct regulating

Detailed Description

Androgen receptor (AR) has been reported to bind to the transcription of SLC1A2 gene in . condition, which leads to an affected expression of the drug transporter Excitatory amino acid transporter 2.

       Transcriptional Phenomenon2

Binding to SLC1A2 gene in prostate cancer condition [9]

TF Protein Name

Androgen receptor Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Androgen receptor (AR) has been reported to bind to the transcription of SLC1A2 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Excitatory amino acid transporter 2.

        HNF4A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC1A2 gene in health condition [10]

TF Protein Name

Hepatocyte nuclear factor 4-alpha Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of SLC1A2 gene in health condition, which leads to an affected expression of the drug transporter Excitatory amino acid transporter 2.

        NR3C1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC1A2 gene in health condition [11]

TF Protein Name

Glucocorticoid receptor Transcription Factor Info

Affected Drug/Substrate

Glutamate

Studied Phenotype

Heallth [ICD11: N.A]

Tissue

Brain

Related DT Changes

Up regulating

Experimental Material

Rats astrocyte isolates

Detailed Description

Glucocorticoid receptor (NR3C1) has been reported to activate the transcription of SLC1A2 gene in health condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 2.

      Class2.3: C2H2 zinc finger factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        YY1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Repression of SLC1A2 gene in health condition [12]

TF Protein Name

Transcriptional repressor protein YY1 Transcription Factor Info

Studied Phenotype

Heallth [ICD11: N.A]

Tissue

Brain

Related DT Changes

down regulating

Experimental Material

YY1-loxP homozygous mice astrocytes

Detailed Description

Transcriptional repressor protein YY1 (YY1), influenced by the exogenous manganese chloride, has been reported to repress the transcription of SLC1A2 gene in health condition , which leads to a decreased expression of the drug transporter Excitatory amino acid transporter 2.

        ZNF217 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC1A2 gene in breast cancer condition [13]

TF Protein Name

Zinc finger protein 217 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Zinc finger protein 217 (ZNF217) has been reported to bind to the transcription of SLC1A2 gene in breast cancer condition, which leads to an affected expression of the drug transporter Excitatory amino acid transporter 2.

TF Superclass3: Helix-turn-helix domains

      Class3.3: Fork head / winged helix factors

Click to Show/Hide the Full List of 4 TF(s) Regulating This DT

        E2F1 

Click to Show/Hide to Show 2 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC1A2 gene in MCF7 cells [7]

TF Protein Name

Transcription factor E2F1 Transcription Factor Info

Related DT Changes

Direct regulating

Detailed Description

Transcription factor E2F1 (E2F1) has been reported to bind to the transcription of SLC1A2 gene in MCF7 cells, which leads to an affected expression of the drug transporter Excitatory amino acid transporter 2.

       Transcriptional Phenomenon2

Binding to SLC1A2 gene in MCF7 condition [14]

TF Protein Name

Transcription factor E2F1 Transcription Factor Info

Related DT Changes

Direct regulating

Detailed Description

Transcription factor E2F1 (E2F1) has been reported to bind to the transcription of SLC1A2 gene in MCF7 condition, which leads to an affected expression of the drug transporter Excitatory amino acid transporter 2.

        FOXA1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC1A2 gene [15]

TF Protein Name

Hepatocyte nuclear factor 3-alpha Transcription Factor Info

Tissue

Breast; Embryo; Liver; Prostate

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC1A2 gene, which in turn affects the expression or function of the drug transporter Excitatory amino acid transporter 2.

        FOXA2 

Click to Show/Hide to Show 2 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC1A2 gene in health condition [10]

TF Protein Name

Hepatocyte nuclear factor 3-beta Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to bind to the transcription of SLC1A2 gene in health condition, which leads to an affected expression of the drug transporter Excitatory amino acid transporter 2.

       Transcriptional Phenomenon2

Direct binding to SLC1A2 gene [16]

TF Protein Name

Hepatocyte nuclear factor 3-beta Transcription Factor Info

Tissue

Colon

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC1A2 gene, which in turn affects the expression or function of the drug transporter Excitatory amino acid transporter 2.

        FOXM1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC1A2 gene in breast cancer condition [17]

TF Protein Name

Forkhead box protein M1 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Forkhead box protein M1 (FOXM1) has been reported to activate the transcription of SLC1A2 gene in breast cancer condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 2.

      Class3.5: Tryptophan cluster factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        IRF1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC1A2 gene in health condition [18]

TF Protein Name

Interferon regulatory factor 1 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Interferon regulatory factor 1 (IRF1) has been reported to activate the transcription of SLC1A2 gene in health condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 2.

TF Superclass6: Immunoglobulin fold

      Class6.1: Rel homology region factors

Click to Show/Hide the Full List of 3 TF(s) Regulating This DT

        EBF1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC1A2 gene [19]

TF Protein Name

Transcription factor COE1 Transcription Factor Info

Tissue

Blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor COE1 (EBF1) can directly bind to the SLC1A2 gene, which in turn affects the expression or function of the drug transporter Excitatory amino acid transporter 2.

        NFKB1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC1A2 gene in astrocytoma condition [5]

TF Protein Name

Nuclear factor NF-kappa-B p105 subunit Transcription Factor Info

Studied Phenotype

Astrocytoma [ICD11: 2A00.0Y]

Tissue

Brain

Related DT Changes

Up regulating

Experimental Material

Human astrocytoma cells (HTB-148)

Detailed Description

Nuclear factor NF-kappa-B p105 subunit (NFKB1) has been reported to activate the transcription of SLC1A2 gene in astrocytoma condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 2.

        RELA 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC1A2 gene in astrocytoma condition [5]

TF Protein Name

Transcription factor p65 Transcription Factor Info

Studied Phenotype

Astrocytoma [ICD11: 2A00.0Y]

Tissue

Brain

Related DT Changes

Up regulating

Experimental Material

Human astrocytoma cells (HTB-148)

Detailed Description

Transcription factor p65 (RELA) has been reported to activate the transcription of SLC1A2 gene in astrocytoma condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 2.

      Class6.2: STAT domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        STAT1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC1A2 gene [20]

TF Protein Name

Signal transducer and activator of transcription 1-alpha/beta Transcription Factor Info

Related DT Changes

Direct regulating

Detailed Description

Signal transducer and activator of transcription 1-alpha/beta (STAT1) has been reported to bind to the transcription of SLC1A2 gene in . condition, which leads to an affected expression of the drug transporter Excitatory amino acid transporter 2.

      Class6.3: p53 domain factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        TP53 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC1A2 gene in atherosclerosis condition [21]

TF Protein Name

Cellular tumor antigen p53 Transcription Factor Info

Studied Phenotype

Atherosclerosis [ICD11: BD40]

Tissue

Liver

Related DT Changes

Up regulating

Experimental Material

Human hepatoblastoma cells (HepG2)

Detailed Description

Cellular tumor antigen p53 (TP53) has been reported to activate the transcription of SLC1A2 gene in atherosclerosis condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 2.

        TP63 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC1A2 gene in health condition [22]

TF Protein Name

Tumor protein 63 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Tumor protein 63 (TP63) has been reported to bind to the transcription of SLC1A2 gene in health condition, which leads to an affected expression of the drug transporter Excitatory amino acid transporter 2.
References
1 High-resolution genome-wide mapping of AHR and ARNT binding sites by ChIP-Seq. Toxicol Sci. 2012 Dec;130(2):349-61.
2 hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. Genomics Proteomics Bioinformatics. 2020 Apr;18(2):120-210. (ID:ENSG00000110436)
3 Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene. 2011;30(20):2319-32.
4 Gene regulation and epigenetic remodeling in murine embryonic stem cells by c-Myc. PLoS One. 2009;4(11):e7839.
5 Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression. EMBO J. 2005 Feb 9;24(3):510-20.
6 Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma. Neuro Oncol. 2013;15(3):279-89.
7 A computational genomics approach to identify cis-regulatory modules from chromatin immunoprecipitation microarray data--a case study using E2F1. Genome Res. 2006;16(12):1585-95.
8 Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. EMBO J. 2010;29(13):2147-60.
9 Integrated expression profiling and ChIP-seq analyses of the growth inhibition response program of the androgen receptor. PLoS One. 2009;4(8):e6589.
10 Molecular interactions between HNF4a, FOXA2 and GABP identified at regulatory DNA elements through ChIP-sequencing. Nucleic Acids Res. 2009;37(22):7498-508.
11 Differential promotion of glutamate transporter expression and function by glucocorticoids in astrocytes from various brain regions. J Biol Chem. 2005 Oct 14;280(41):34924-32.
12 Astrocyte-specific deletion of the transcription factor Yin Yang 1 in murine substantia nigra mitigates manganese-induced dopaminergic neurotoxicity. J Biol Chem. 2020 Nov 13;295(46):15662-15676.
13 Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha. BMC Genomics. 2014;15(1):520.
14 Genome-wide analysis of transcription factor E2F1 mutant proteins reveals that N- and C-terminal protein interaction domains do not participate in targeting E2F1 to the human genome. J Biol Chem. 2011;286(14):11985-96.
15 NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(D1):D991-5.
16 Closure of the NCBI SRA and implications for the long-term future of genomics data storage. Genome Biol. 2011;12(3):402.
17 FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index. Breast Cancer Res Treat. 2015;154(1):23-32.
18 A ChIP-chip approach reveals a novel role for transcription factor IRF1 in the DNA damage response. Nucleic Acids Res. 2009;37(4):1073-85.
19 The Encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res. 2018 Jan 4;46(D1):D794-D801
20 MER41 repeat sequences contain inducible STAT1 binding sites. PLoS One. 2010;5(7):e11425.
21 p53, a novel regulator of lipid metabolism pathways. J Hepatol. 2012 Mar;56(3):656-62.
22 Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation. Nucleic Acids Res. 2012;40(15):7190-206.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.